Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with gaucher disease

JIMD Reports

Volumn 18, Issue , 2015, Pages 107-115

  Sotiropoulos, Christos ^a   Theodorou, George ^a   Repa, Constantina ^b   Marinakis, Theodoros ^c   Verigou, Eugenia ^a   Solomou, Elena ^a   Karakantza, Marina ^a   Symeonidis, Argiris ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84984605261     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_357     Document Type: Chapter

References (35)

1. Aker M, Zimran A, Abrahamov A, Horowitz M, Matzner Y (1993) Abnormal neutrophil chemotaxis in Gaucher disease. Brit J Haematol 83:187–191
2. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: increased release of interleukin-6 and interleukin-10. QJM 90:19–25
3. Arends M, van Dussen L, Biegstraaten M, Hollak CE (2013) Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature. Br J Haematol 161:832–842
4. Balreira A, Lacerda L, Miranda CS, Arosa FA (2005) Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br J Haematol 129:667–676
5. Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, Yatziv S (1999) Cytokines in Gaucher’s disease. Eur Cytokine Network 10:205–210
6. Bass HZ, Hardy WD, Mitsuyasu RT, Wang YX, Cumberland W, Fahey JL (1992) Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr 5:890–897
7. Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353–360
8. Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA (2000) Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 27:1128–1135
9. Braudeau C, Graveleau J, Rimbert M, Néel A, Hamidou M, Grosbois B, Besançon A et al (2013) Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease. Blood Cells Mol Dis 50:281–288
10. Brusko T, Wasserfall CH, Hulme MA, Cabrera R, Schatz D, Atkinson MA (2009) Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PloS One 4:e7980
11. Burstein Y, Zakuth V, Rechavi G, Spirer Z (1987) Abnormalities of cellular immunity and natural killer cells in Gaucher’s disease. J Clin Lab Immunol 23:149–151
12. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, Park JH, Adelsberger J et al (2011) CD4 and CD8 T cell immune activation during chronic HIV infection-role of homeostasis, HIV, Type I IFN, and IL-7. J Immunol 186:2106–2116
13. de Fost M, Out TA, de Wilde FA, Tjin EP, Pals ST, van Oers MH, Boot RG et al (2008) Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature. Ann Hematol 87:439–449
14. Deegan PB, Moran MT, McFarlane I, Schofield JP, Boot RG, Aerts JM, Cox TM (2005) Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells Mol Dis 35:259–267
15. Hong Y, Kim EY, Jung SC (2006) Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse. J Korean Med Sci 21:733–748
16. Jelley-Gibbs DM, Dibble JP, Filipson S, Haynes L, Kemp RA, Swain SL (2005) Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med 201:1101–1112
17. Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, Stein M, Bentwich Z (1998) Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 114:414–421
18. Karakantza M, Theodorou GL, Mouzaki A, Theodori E, Vagianos C, Maniatis A (2004) In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand J Immunol 59:209–219
19. Lacerda L, Arosa FA, Lacerda R, Cabeda J, Porto G, Amaral O, Fortuna A et al (1999) T cell numbers relate to bone involvement in Gaucher disease. Blood Cells Mol Dis 25:130–138
20. LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W (2004) Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 34:1513–1525
21. Liu J, Halene S, Yang M, Iqbal J, Yang R, Mehal WZ, Chuang WL et al (2012) Gaucher disease gene GBA functions in immune regulation. PNAS 109:10018–10023
22. Maródi L, KÄposzta R, TóthJ LA (1995) Impaired microbicidal capacity of mononuclear phagocytes from patients with GD type I disease: partial correction by enzyme replacement therapy. Blood 86:4645–4649
23. Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CE, Van Oers MH, Aerts JM (1996) TNF-∝ levels in Gaucher disease. Biochim Biophys Acta Mol Basis Dis 1317:219–222
24. Micheva I, Marinakis T, Repa C, Kouraklis-Symeonidis A, Vlacha V, Anagnostopoulos N, Zoumbos N et al (2006) Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal. Blood Cells Mol Dis 36:298–307
25. Pandey M, Rani R, Zhang W, Setchell K, Grabowski GA (2012) Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease. Mol Genet Metab 106:310–320
26. Pérez Calvo J, Iñigo-Gil P, Giraldo-Castellano P, Torralba-Cabeza MA, Civeira F, Lario-García S, Pocoví M. (2000) Transforming growth factor beta (TGF-beta) in Gaucher’s disease. Preliminary results in a group of patients and their carrier and non-carrier relatives (Article in Spanish). Med Clin (Barc) 115:601–604
27. Rogowski O, Shapira I, Zimran A, Zeltser D, ElsteinD AD, Bashkin A et al (2005) Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol Dis 34:26–29
28. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21:1105–1111
29. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM (2001) Control of T-cell activation by CD4+CD25+ suppressor T cells. Immunol Rev 182:58–67
30. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J (1982) Gaucher’s disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388–391
31. Shoenfeld Y, Beresovski A, Zharhary D, Tomer Y, Swissa M, Sela E, Zimran A et al (1995) Natural autoantibodies in sera of patients with Gaucher’s disease. J Clin Immunol 15:363–372
32. Smolenska Z, Pawłowska J, Zdrojewski Z, Daca A, Bryl E (2012) Increased percentage of CD8+CD28-T cells correlates with clinical activity in primary Sjögren’s syndrome. Cell Immunol 278:143–151
33. Symeonidis A, Liga M, Triantafyllou E, Kouraklis A, Tiniakou M, Karakantza M, Spyridonidis A, Zoumbos N (2011) Successful mobilization with plerixafor and autologous hematopoietic stem cell transplantation in a patient with refractory Hodgkin’s lymphoma and Gaucher disease. Bone Marrow Transplant 46:1161–1162
34. Volk HD, Kopp J, Körner IJ, Jahn S, Grunow R, Barthelmes H, Fiebig H (1986) Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus. Scand J Immunol 24:109–114
35. Wilson JW, Djukanović R, Howarth PH, Holgate ST (1994) Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Resp Crit Care Med 1994(149):86–90